Yale Cardiology
Clinic Building
789 Howard Avenue
New Haven, CT 06519
- Directions
Yale Cardiology
Yale New Haven Hospital
20 York Street
New Haven, CT 06510
- Directions
Yale Heart and Vascular Outpatient Services
84 North Main Street
Branford, CT 06405
- 1-203-483-8300
- Directions
Yale Cardiology
Yale Physicians Building
800 Howard Avenue
New Haven, CT 06519
- Directions

Frank Giordano, MD

Cardiovascular Medicine, Interventional Cardiology

Telehealth is available

Learn more about telehealth

Patient type treated

Adult

Accepting new patients

Yes

Referral required

From patients or physicians

Board Certified in

Internal Medicine

Insurance accepted

View Academic Profile

Click here to view more about this specialist's research and educational efforts on https://medicine.yale.edu

Click here to view more about this specialist's research and educational efforts onhttps://medicine.yale.edu

Titles

Associate Professor of Medicine (Cardiology)

Education & Training

Fellow
University of California, San Diego (1994)
Fellow
University of California, San Diego (1992)
Resident
Loyola University (1990)
MD
Loyola Stritch School of Medicine (1986)
BS
University of Illinois (1980)

Additional Information

Board Certifications

Publications

Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.
Henry TD, Rocha-Singh K, Isner JM, Kereiakes DJ, Giordano FJ, Simons M, Losordo DW, Hendel RC, Bonow RO, Eppler SM, Zioncheck TF, Holmgren EB, McCluskey ER. Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease. American Heart Journal 2001, 142: 872-80. PMID: 11685177, DOI: 10.1067/mhj.2001.118471.
Blood pressure changes and pharmacokinetics following vascular endothelial growth factor (rhVEGF) infusion in humans (In preparation).
Eppler SM, McCluskey ER, Bloedow DC, Henry TD, Simons M, Giordano FJ, Zioncheck TF. Blood pressure changes and pharmacokinetics following vascular endothelial growth factor (rhVEGF) infusion in humans (In preparation).
INK4B gene expression induces apoptosis in vascular smooth muscle cells and morphometric changes in cardiac myocytes and skeletal myoblasts (In preparation)
Giordano FJ, Katragadda R, Rothman A, Lu C-Y: INK4B gene expression induces apoptosis in vascular smooth muscle cells and morphometric changes in cardiac myocytes and skeletal myoblasts (In preparation).
Infusion of VEGF by Intracoronary or Intravenous Route Ameliorates Ischemia Induced Contractile Abnormalities in the Pig (In preparation).
Giordano FJ, Ross Jr J, Peterson KL, Dalton N, McCluskey T, Zionchek T, McKirnan MD: Infusion of VEGF by Intracoronary or Intravenous Route Ameliorates Ischemia Induced Contractile Abnormalities in the Pig (In preparation).
Intravenous administration of recombinant human vascular endothelial growth factor (rhVEGF) in patients with ischemic heart disease (In preparation).
Simons M, Giordano FJ, Henry TD, Powell JS, Azrin MA, Kereiakes DJ, Annex B, Miller JM, Gibson CM, Lewin HC, Berman DS, McCluskey ER: Intravenous administration of recombinant human vascular endothelial growth factor (rhVEGF) in patients with ischemic heart disease (In preparation).
A Remote Role for Renalase.
Giordano FJ, Wang Y, Desir GV. A Remote Role for Renalase. EBioMedicine 2016, 9: 27-28. PMID: 27374133, PMCID: PMC4972559, DOI: 10.1016/j.ebiom.2016.06.034.

Patient Care Organizations